We – The Group Action Lawyers – have been fighting for the rights of people pursuing emissions compensation claims since the start of the ‘dieselgate’ issues in 2015.
Thousands of people have signed up for cases with us since 2015 against a range of vehicle manufacturers embroiled in recalls and alleged scandals. This includes the Volkswagen cases (please note we can no longer take claims forward for that one), the Mercedes cases and others. In recent weeks, a large number of new clients have signed up for cases with us, and we are still taking new claims forward on a No Win, No Fee basis for Mercedes and Nissan/Renault owners.
You can find out today if we can help you.
News of the Johnson & Johnson pelvic mesh settlements in Scotland are welcome here at the Group Action Lawyers as the wider fight for justice continues.
Settlements have now been achieved for thousands of people worldwide, and millions of pounds in damages have been paid out. But the battle for many women rages on, and we represent people for cases here in England and Wales.
Here, we will briefly cover the settlement in Scotland and how this affects vaginal mesh claimants in the rest of the UK.
We are taking forward Mercedes emissions compensation claims in the same way that we have represented thousands for cases against Volkswagen, Porsche and Jaguar.
When we first took action against VW for their huge emissions scandal back in 2015, we strongly suspected that they would not be the only manufacturer to be investigated. Since then, other vehicle makers have been involved with legal actions and have initiated recalls around the world over emissions irregularities.
As we suspected, the VW scandal was the tip of the iceberg.
We are taking claims forward for Mercedes (Daimler) owners whose vehicles have been subject to recalls. We can represent clients on a No Win, No Fee basis for claims.
Drugs recall compensation claims can form into group and multi-party actions when users have suffered as a result of a problem with the manufacturers or the suppliers.
The impact for the victims in these kinds of cases can, of course, be severe; especially if the drugs being recalled are for serious or even life-threatening conditions. Even the fact that there is a recall can be worrying for the patients who are told to stop taking their medication and seek replacements.
When these kinds of recalls happen, they can lead to group action compensation claims if the impact on the victims is severe enough. Groups could range from just a small number of victims who were unlucky enough to be affected, to thousands of people who may have suffered.
Patient information leaflet errors can, in the worst-case scenarios, cause severe problems for those who have used the wrong medication or used meds incorrectly due to the error.
When these scenarios happen, a recall will usually be launched and announced via the Medicines and Healthcare products Regulatory Agency (MHRA). Information about the recall will normally be distributed so that patients can be made aware, but this won’t always stop an adverse incident from occurring.
With this in mind, here’s a little advice about what to do if you have suffered harm as a result of following the incorrect information for medication or a product in general.
A medical device alert has been issued and published by the MHRA in relation to Ethicon surgical staplers, which have reportedly caused injury to some patients.
It’s understood that there’s a risk that some of the devices manufactured from March 2018 have not been working properly. Reported issues include the devices misfiring or failing to fire the staples during surgery. The MHRA (Medicines and Healthcare products Regulatory Agency) say that there has been increased complaints of malformed stables with some devices being returned.
With this issue involving invasive surgery, the alert is one that needs to be taken incredibly seriously.
The Raindrop Near Vision Inlay recall has been initiated due to an increased risk of corneal haze that patients implanted with the devices may experience.
A Medical Device Alert was issued via the MHRA (Medicines and Healthcare products Regulatory Agency) a few weeks ago. There’s a warning to not implant Raindrop Near Vision Inlays and to dispose of any unused stock of them.
Any patients who have already been implanted with the inlays are to be monitored, and any incidents and problems are to be reported. This recall follows the recent news coverage about the Oculentis recall, which is one of the compensation actions we’re representing people for.
If you’re suffering with elbow implant problems, you may want to read this. The recent Stryker recall could be linked to any complications you’re experiencing.
Back in November 2017, a Field Safety Notice was filed for a recall of the rHead Radial Head and the Uni-Elbow prosthesis. In February this year, a medical device alert was put out by the MHRA (Medicines and Healthcare products Regulatory Agency). Urgent actin is to be taken, and any patient suffering should seek medical advice.
The problems that could be caused that are linked to this recall can be serious. Having recovered over £1.3m in damages for victims of the PIP implant scandal, as well as representing Claimants in hip implant cases and other medical device actions, these kinds of claims are one of our primary specialisms.
If you’re suffering with valsartan side effects, you may want to read this article and take heed of some important information about the drug.
Last year, a Class 1 Medicines Recall was initiated by Medicines and Healthcare products Regulatory Agency (MHRA). The recall stems from potential contamination that comes from the production process that could be incredibly serious for anyone affected. In fact, in the US, lawsuits have been active for some time now. When members of the Group Action Lawyers attended a conference in the U.S. last year, it was clear to us just how serious this issue could be.
If you’ve been taking the medication here in the UK and you’ve suffered problems or side effects, we may need to speak with you.
If you’ve yet to initiate your legal action for Oculentis compensation, make sure you speak to our team as soon as you possibly can.
In this type of action, there can be complicated (and multiple) time limits to claim. Missing one or more of these deadlines could mean the difference between receiving thousands of pounds in compensation or getting absolutely nothing at all.
You may be eligible to claim Oculentis compensation if you’re one of the hundreds of people affected by the recall of their intraocular lenses.
The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).
Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some Valsartan products were contaminated. Legal cases are already underway, and this latest recall involves further batches of the product.
An immediate suspension and quarantine of the additional affected products has been ordered.
Were you affected by the cough syrup mould issues that came to light over summer? In the midst of the season for colds and coughs, you may want to take heed of this warning if you’re not aware of it already.
Over summer, a formal recall was issued with the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency. This was a Class 2 Medicines recall for own-brand glycerine and blackcurrant cough syrup products manufactured for children by Bell, Sons & Co.
As these are marketed as own-brand products, it’s the likes of Asda, Morrisons, Sainsbury’s and Tesco at the centre of this recall.